BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15978630)

  • 1. Lipid rafts: a nexus for endocannabinoid signaling?
    McFarland MJ; Barker EL
    Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
    McFarland MJ; Terebova EA; Barker EL
    AAPS J; 2006 Mar; 8(1):E95-100. PubMed ID: 16584138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
    Quest AF; Leyton L; Párraga M
    Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
    Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endocannabinoids and endovanilloids in Ca2+ signalling.
    De Petrocellis L; Di Marzo V
    Cell Calcium; 2009 Jun; 45(6):611-24. PubMed ID: 19356798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid signalling system: biochemical aspects.
    Bisogno T; Ligresti A; Di Marzo V
    Pharmacol Biochem Behav; 2005 Jun; 81(2):224-38. PubMed ID: 15935454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
    Onaivi ES
    Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.
    Patel HH; Murray F; Insel PA
    Handb Exp Pharmacol; 2008; (186):167-84. PubMed ID: 18491052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.
    Grimaldi C; Capasso A
    Mini Rev Med Chem; 2012 Oct; 12(11):1119-26. PubMed ID: 22625418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.
    Barnett-Norris J; Lynch D; Reggio PH
    Life Sci; 2005 Aug; 77(14):1625-39. PubMed ID: 15993425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular signaling through cholesterol-rich domains: implications in hypertension.
    Callera GE; Montezano AC; Yogi A; Tostes RC; Touyz RM
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):90-104. PubMed ID: 17293683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes.
    Insel PA; Head BP; Ostrom RS; Patel HH; Swaney JS; Tang CM; Roth DM
    Ann N Y Acad Sci; 2005 Jun; 1047():166-72. PubMed ID: 16093494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
    Jonsson KO; Holt S; Fowler CJ
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system and gut-brain signalling.
    Storr MA; Sharkey KA
    Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic modulation by endocannabinoids.
    Lovinger DM
    Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.